Jacques De Jong is an interesting study. Now at Philips (since June 15) as a QA Manager, his last role (minus a short stint (2 months) at Dekra) was with Future DX as a principal scientist/technical architect. Previous to this he was with bioMerieux for 7 years where he was Director of Immunodiagnostics R&D and then Director of Molecular Diagnostics. One could assume he has experience with our technology and is in a position to use it. From his bio:
"I am a medical biologist, with a Ph.D in Immunology. I have considerable experience in the In Vitro Diagnostic industry and have held since 1998 various positions in R&D (Principal Scientist, Project Manager, Department head). I have gained extensive knowledge of GMP, GLP regulations, CE marking and FDA submission"
Jacques De Jong is an interesting study. Now at Philips (since...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.79M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.0¢ | $3.965K | 195.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1417631 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 95237 | 1 |
View Market Depth
| Last trade - 14.20pm 11/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |